"Daunorubicin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A very toxic anthracycline aminoglycoside antineoplastic isolated from Streptomyces peucetius and others, used in treatment of LEUKEMIA and other NEOPLASMS.
Descriptor ID |
D003630
|
MeSH Number(s) |
D02.455.426.559.847.562.050.200 D04.615.562.050.200 D09.408.051.059.200
|
Concept/Terms |
Daunorubicin- Daunorubicin
- Daunomycin
- Rubomycin
- Dauno-Rubidomycine
- Dauno Rubidomycine
- Rubidomycin
|
Below are MeSH descriptors whose meaning is more general than "Daunorubicin".
Below are MeSH descriptors whose meaning is more specific than "Daunorubicin".
This graph shows the total number of publications written about "Daunorubicin" by people in this website by year, and whether "Daunorubicin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
2014 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Daunorubicin" by people in Profiles.
-
Multicomponent Synthesis, Binding Mode, and Structure-Activity Relationship of Selective Histone Deacetylase 6 (HDAC6) Inhibitors with Bifurcated Capping Groups. J Med Chem. 2020 09 24; 63(18):10339-10351.
-
Daunorubicin during delayed intensification decreases the incidence of infectious complications - a randomized comparison in trial CoALL 08-09. Leuk Lymphoma. 2019 01; 60(1):60-68.
-
Recurrent RHOA mutations in pediatric Burkitt lymphoma treated according to the NHL-BFM protocols. Genes Chromosomes Cancer. 2014 Nov; 53(11):911-6.
-
Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92. Leukemia. 1996 Jun; 10(6):957-63.
-
Poor prognosis of prethymic phenotype acute lymphoblastic leukemia (pre-T-ALL). Leukemia. 1994 Aug; 8(8):1406-8.